The Employment of Biocompatible Nanomaterials for Disease Diagnosis and Treatment Based on Catalytic Reactions

A special issue of Catalysts (ISSN 2073-4344). This special issue belongs to the section "Catalysis for Pharmaceuticals".

Deadline for manuscript submissions: 15 July 2025 | Viewed by 116

Special Issue Editor


E-Mail Website
Guest Editor
Center for Advanced Low-Dimension Materials, State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai, China
Interests: nanozyme; photocatalysts; hybrid material; tumor therapy; sterilization; tissue engineering
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Recent advancements in nanochemistry have ushered in an array of novel nanocatalysts, including nanoenzymes, photocatalysts, and electrocatalysts. These have been utilized in vivo to initiate catalytic reactions and modulate the biological microenvironment for therapeutic benefits. With the swift progression of nanocatalysts in biomedical applications, a new paradigm, "nanocatalytic medicine", has emerged. This concept is defined as "the employment of biocompatible nanomaterials for disease diagnosis and treatment based on catalytic reactions".

By introducing non-toxic or minimally toxic nanocatalysts into pathological areas, therapeutic chemical reactions are "catalyzed", fostering a more biocompatible and sustainable approach. In these catalyzed reactions, the reactants are typically the inherent biochemicals of the pathological region, as opposed to delivered therapeutic agents. "Nanocatalytic medicine" directs catalytic reactions to optimize therapeutic outcomes, effectively translating the catalytic efficiencies and selectivity that chemists have strived to achieve over the past century into high-performance therapeutic diagnostics with reduced side effects.

In recent years, this burgeoning catalytic therapeutic modality has significantly contributed to advancements in various areas of nanomedicine. It has offered effective therapeutic strategies for a broad spectrum of pathological abnormalities, ranging from cancer, bacterial infections, and inflammation to brain injury and other diseases.

The aim of this Special Issue is to compile a collection of articles focused on nanocatalytic medicine. We cordially invite scholars and experts from relevant scientific disciplines to contribute their academic works.

Prof. Dr. Yi Wang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Catalysts is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanozymes
  • photocatalysts
  • biomedicine
  • tumor therapy
  • tissue engineering

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop